Vanguard Fiduciary Trust
SONM icon

Vanguard Fiduciary Trust’s DNA X Inc SONM Stock Holding History

Vanguard Fiduciary Trust’s Portfolio SONM Stock Details SONM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23K Hold
4,496
– – ﹤0.01% 3980
2026
Q1 		$18.1K Buy
+4,496
New +$21.2K ﹤0.01% 3962

Other funds holding SONM

CWM
C2C Wealth Management Scottsdale, Arizona $128M AUM 22.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Vanguard Fiduciary Trust's SONM Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its DNA X Inc (SONM) position steady in Q2 2026 at 4,496 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #3980.

Vanguard Fiduciary Trust first reported a position in SONM in Q1 2026 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold SONM as of Q2 2026.

  • Vanguard Fiduciary Trust held 4,496 shares of DNA X Inc worth $23K as of Q2 2026.
  • Vanguard Fiduciary Trust left its DNA X Inc share count unchanged in Q2 2026.
  • DNA X Inc made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3980 holding.
  • Vanguard Fiduciary Trust first reported a position in DNA X Inc in Q1 2026 and has held it in 2 quarters since.
  • 9 funds tracked by Wall St. Rank held DNA X Inc as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.